Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7410 p106
22 July 2006

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

· Professional regulation
· Code of Ethics (2)
· The profession (4)
· Community pharmacy (2)
· Multiples
· Accuracy checking
· CPPE (3)
· Medicines use review
· Emergency supplies (2)
· Controlled Drugs
· NHS
· Nutrition
· Fellowship
· The Council
· Retention fees
· Section 60 Order


Letters to the Editor

Fellowship

Panel of Fellows makes decisions based on distinction

From Mr R. J. S. Hazlehurst, FRPharmS

By publishing the letter from Ewa Hopkins (PJ, 15 July, p75), you have effectively identified Steve Williams as the object of her wrath, albeit it was the decision of the Panel of Fellows which she criticised.

Since I retired from the panel at the meeting immediately before Mr Williams’s proposal must have been discussed, I can also comment from personal experience on the process, without fear of compromising what was, of course, a confidential discussion.

Having been a member of the Pharmaceutical Services Negotiating Committee for as long as Mr Williams, I can comment from personal experience on his work as chairman of the funding and contract subcommittee.

I can think of no one who has more care and concern for his fellow pharmacists, with a more thorough understanding of the detail, funding and other issues underlying the new contract, than Mr Williams.

No one could have given more fully of his considerable ability and energy for the advancement of community pharmacy. His knowledge and understanding included a degree of pragmatism which Mrs Hopkins, it seems, lacks. He realised and understood that it would be impossible to please everyone with the proposed structure of the new contract; but the size of the vote in support of it was testimony to how small a proportion of contractors felt themselves to be disaffected.

Mr Williams was a major force in moving community pharmacy forward into a new age; his contribution to the profession was enormous and certainly merits the term “distinction”.

It is distinction which the Panel of Fellows needs to recognise before it grants a fellowship.

I have no doubt that the panel saw distinction, even if Mrs Hopkins does not; Mr Williams has demonstrated distinction in abundance, and above and beyond the call of duty.

It is, of course, possible for members of the panel to recognise distinction while not liking personally the activity which constituted it (though I do not even remotely suggest that was the case in this instance), and it is regrettable that Mrs Hopkins was unable to do the same.

Dick Hazlehurst
Secretary, Bradford Local Pharmaceutical Committee

Send your letter to The Editor

Previous Topic (Nutrition)
Next Topic (The Council)

Back to Top


©The Pharmaceutical Journal